Skip to content
DraconiticResearch
Search Sources API
197,768 studies31 sourcesUpdated 17 min ago
Peer-reviewedCC BYMolecules (Basel, Switzerland)

Novel 2,4-Pyrimidinediamine Derivative as Potent EGFR Inhibitor for NSCLC Treatment

  • Shiqi Jia1
  • Xiaolin Lv2
  • Jia Lv2
  • Yiran Wu3
  1. 1University of Science and Technology of China, Hefei 230026, China
  2. 2Changchun University of Science and Technology College of Optical and Electronic Information, Changchun 130114, China; (X.L.); (J.L.)
  3. 3iHuman Institute, ShanghaiTech University, Shanghai 201210, China;
Read full textPDFCite

Related

  1. Multifunctional investigation of a chalcone derivative: nonlinear optical properties, and potent antifungal activity
    Varsha. V. Koppal, Rekha. K. Hebasur, Ninganagouda. R. Patil +7
    Scientific ReportsPeer-reviewedCC BYFull textMaterials & polymersDOAJ
  2. Structural Analysis of HRF-4467, a Potent Second-Generation HIV-1 Maturation Inhibitor
    Kiran Kumar, Theodore J. Nitz, Carl T. Wild +2
    ChemRxivPreprintLicence not statedGeneral chemistryChemRxiv
  3. A Potent Solution for Tumor Growth and Angiogenesis Suppression via an ELR⁺CXCL-CXCR1/2 Pathway Inhibitor
    Oleksandr Grytsai, Maeva Dufies, Julie Le Du +9
    ACS Medicinal Chemistry LettersPeer-reviewedPublisher termsFull text3 citedGeneral biologyMedicinal chemistry & drug discoveryHAL
  4. Novel Synthetic Chalcones Display Potent Anti-Leishmania (Viannia) braziliensis Profile and Inhibit Proteolytic Activities
    Edgar Schaeffer, Geovane Dias-Lopes, Patrícia Queiroz Monteiro +5
    ACS omegaPeer-reviewedCC BYFull textGeneral chemistryEurope PMC
  5. Design, synthesis, and biological evaluation of novel triazolopyrimidine–1,2,3-triazole–acetamide hybrids as potent α-glucosidase inhibitors supported by in silico studies
    Fariba Peytam, Mahmood Biglar, Bahareh Bayati +7
    Scientific ReportsPeer-reviewedCC BY-NC-ND 4.0Full textOrganic chemistryCrossref

Cite

BibTeXRIS
BibTeX
@article{jia2026novel,
  title = {{Novel 2,4-Pyrimidinediamine Derivative as Potent EGFR Inhibitor for NSCLC Treatment}},
  author = {Shiqi Jia and Xiaolin Lv and Jia Lv and Yiran Wu},
  journal = {Molecules (Basel, Switzerland)},
  year = {2026},
  month = sep,
  url = {https://europepmc.org/article/PMC/PMC13666482},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Novel 2,4-Pyrimidinediamine Derivative as Potent EGFR Inhibitor for NSCLC Treatment
AU  - Shiqi Jia
AU  - Xiaolin Lv
AU  - Jia Lv
AU  - Yiran Wu
PY  - 2026
DA  - 2026/09/27
JO  - Molecules (Basel, Switzerland)
UR  - https://europepmc.org/article/PMC/PMC13666482
SN  - 1420-3049
ER  -